Mikaël Chetboun,Elodie Drumez,Cassandra Ballou,Mehdi Maanaoui,Elizabeth Payne,Franca Barton,Julie Kerr-Conte,Marie-Christine Vantyghem,Lorenzo Piemonti,Michael R Rickels,Julien Labreuche,François Pattou,Collaborative Islet Transplant Registry (CITR) Investigators study group,R Alejandro,M Aull,M Bellin,T Berney,D Borja-Cacho,K Brayman,E Cagliero,R Caiazzo,M Cattral,T Coates,K Danielson,F Defrance,E De Koning,C Desai,N Desai,A O Gaber,V Gmyr,P Gores,J A Goss,P Gottllieb,C Greenbaum,M Hardy,D Harlan,B Hering,F Kandeel,D Kaufman,T Kay,B Keymeulen,K Khan,Y Kudva,C Larsen,K Le Mapihan,G Levy,M Levy,T Loudovaris,T Lundgren,P Maffi,J Markmann,W H Marks,A Naji,P O'Connell,J Oberholzer,J Odorico,N Onaca,F Pattou,L Piemonti,D Pipeleers,A Posselt,A Rajab,V Raverdy,M R Rickels,C Ricordi,A A Rossini,F Saudek,B Schrope,A Secchi,P Senior,A M J Shapiro,J Shaw,P Stock,D Thomas,M J Thompson,M C Vantyghem,L Vargas,H Wang,A Wiseman,P Witkowski,K Yoon

Abstract:Background: Allogeneic islet transplantation is a validated therapy in type 1 diabetes; however, there is decline of transplanted islet graft function over time and the mechanisms underlying this decline are unclear. We evaluated the distinct association between primary graft function (PGF) and 5-year islet transplantation outcomes. Methods: In this retrospective, multicentre, observational cohort study, we enrolled all patients from the Collaborative Islet Transplant Registry who received islet transplantation alone (ITA recipients) or islet-after-kidney transplantation (IAK recipients) between Jan 19, 1999, and July 17, 2020, with a calculable PGF (exposure of interest), measured 28 days after last islet infusion with a validated composite index of islet graft function (BETA-2 score). The primary outcome was cumulative incidence of unsuccessful islet transplantation, defined as an HbA1c of 7·0% (53 mmol/mol) or higher, or severe hypoglycaemia (ie, requiring third-party intervention to correct), or a fasting C-peptide concentration of less than 0·2 ng/mL. Secondary outcomes were graft exhaustion (fasting C-peptide <0·3 ng/mL); inadequate glucose control (HbA1c ≥7·0% [53 mmol/mol] or severe hypoglycaemia); and requirement for exogenous insulin therapy (≥14 consecutive days). Associations between PGF and islet transplantation outcomes were explored with a competing risk analysis adjusted for all covariates suspected or known to affect outcomes. A predictive model based on PGF was built and internally validated by using bootstraps resampling method. Findings: In 39 centres worldwide, we enrolled 1210 patients with a calculable PGF (of those without missing data, mean age 47 years [SD 10], 712 [59·5%] were female, and 865 (97·9%) were White), who received a median of 10·8 thousand islet-equivalents per kg of bodyweight (IQR 7·4-13·5). 986 (82·4%) were ITA recipients and 211 (17·6%) were IAK recipients. Of 1210 patients, 452 (37·4%) received a single islet infusion and 758 (62·6%) received multiple islet infusions. Mean PGF was 14·3 (SD 8·8). The 5-year cumulative incidence of unsuccessful islet transplantation was 70·7% (95% CI 67·2-73·9), and was inversely and linearly related to PGF, with an adjusted subhazard ratio (sHR) of 0·77 (95% CI 0·72-0·82) per 5-unit increase of BETA-2 score (p<0·0001). Secondary endpoints were similarly related to PGF. The model-adjusted median C-statistic values of PGF for predicting 5-year cumulative incidences of unsuccessful islet transplantation, graft exhaustion, inadequate glucose control, and exogenous insulin therapy were 0·70 (range 0·69-0·71), 0·76 (0·74-0·77), 0·65 (0·64-0·66), and 0·72 (0·71-0·73), respectively. Interpretation: This global multicentre study reports a linear and independent association between PGF and 5-year clinical outcomes of islet transplantation. The main study limitations are its retrospective design and the absence of analysis of complications. Funding: Public Health Service Research, National Institutes of Health, Juvenile Diabetes Research Foundation International, Agence National de la Recherche, Fondation de l'Avenir, and Fonds de Dotation Line Renaud-Loulou Gasté.

β-Cell Secretory Capacity Predicts Metabolic Outcomes over 6 Years following Human Islet Transplantation

Insulin independence following islet transplantation improves long-term metabolic outcomes

The Influences of Islet Transplantation on Metabolic Abnormalities and Diabetic Complications.

Islet Alone Versus Islet after Kidney Transplantation: Metabolic Outcomes and Islet Graft Survival

Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry

The journey of islet cell transplantation and future development

Insulin independence following isolated islet transplantation and single islet infusions.

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Long-term Tolerance to Islet Transplantation via Targeted Reduction of beta cell-specific T cells.

Brown Adipose Tissue as a Unique Niche for Islet Organoid Transplantation: Insights From In Vivo Imaging

Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience

IAPP Marks Mono-hormonal Stem-cell Derived β Cells that Maintain Stable Insulin Production in vitro and in vivo

Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).

Longitudinal multimodal monitoring of transplanted islet β-cells

Imaging prediction of islet yield and post-operative insulin requirement in children undergoing total pancreatectomy with islet autotransplantation

1729-P: Role of ß-Cell Senescence in Islet Transplantation

Phase 3 trial of human islet‐after‐kidney transplantation in type 1 diabetes

Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia

IAPP Marks Mono-hormonal Stem-cell Derived β Cells that Maintain Stable Insulin Production and

Assessment of the relationship between hypoglycaemia awareness and autonomic function following islet cell/pancreas transplantation

Multi-omics analysis of long-term cultured human islets